Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.03 +0.33 (+8.78%)
As of: Sep 29, 2026 · 3:59 PM EDT

Recursion Pharmaceuticals (RXRX) Total Current Liabilities (2020 - 2026)

Updated

Recursion Pharmaceuticals' Total Current Liabilities was $119.89 million in Q2 2026, down 26.9% from $164.03 million a year earlier and down 7.6% from the prior quarter.

Analysis

Recursion Pharmaceuticals (RXRX) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Recursion Pharmaceuticals came in at $147.71 million, down 21.2% from FY2024.

  • Total Current Liabilities shows a five-year compound annual growth rate of 44.9% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $187.47 million in FY2024 (+101.2%), $93.17 million in FY2023 (-7.1%), $100.27 million in FY2022 (+114.9%) and $46.66 million in FY2021 (+102.0%).
  • The Q2 2026 figure marks the lowest quarterly Total Current Liabilities since Q3 2024.
  • Compared with a year earlier, Total Current Liabilities has declined for three straight quarters, with growth averaging 35.6% over the last eight quarters.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q2 2022 (growth of 227.2%); the worst was Q2 2026 (a decline of 26.9%).
  • Per Business Quant data, RXRX's Total Current Liabilities in the three quarters before Q2 2026 was $129.7 million (Q1 2026), $147.71 million (Q4 2025) and $155.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Recursion Pharmaceuticals 1.98 Bn -627.04 Mn -3.82 Mn 119.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 119.89 Mn
Mar 31, 2026 129.70 Mn
Dec 31, 2025 147.71 Mn
Sep 30, 2025 155.10 Mn
Jun 30, 2025 164.03 Mn
Mar 31, 2025 141.98 Mn
Dec 31, 2024 187.47 Mn
Sep 30, 2024 108.89 Mn
Jun 30, 2024 86.08 Mn
Mar 31, 2024 73.92 Mn
Dec 31, 2023 93.17 Mn
Sep 30, 2023 94.12 Mn
Jun 30, 2023 113.96 Mn
Mar 31, 2023 92.15 Mn
Dec 31, 2022 100.27 Mn
Sep 30, 2022 83.04 Mn
Jun 30, 2022 96.65 Mn
Mar 31, 2022 85.71 Mn
Dec 31, 2021 46.66 Mn
Sep 30, 2021 42.94 Mn
API Access

Recursion Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=RXRX&period=max&api_key=YOUR_API_KEY